To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunteers To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211in Health ...
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose in Healthy Volunteers and Autosomal Dominant Polycystic Kidney Disease Subjects Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose in Healt ...
Autosomal Dominant Polycystic Kidney
Drug: AL01211 or Placebo (Part A);Drug: AL01211 or Placebo (Part B)